{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:58:21Z","timestamp":1772924301714,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T00:00:00Z","timestamp":1532736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1054146"],"award-info":[{"award-number":["1054146"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00228-018-2525-2","type":"journal-article","created":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T17:51:55Z","timestamp":1532800315000},"page":"1523-1529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Barriers and facilitators of appropriate vancomycin use: prescribing context is key"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-3960","authenticated-orcid":false,"given":"Joanne Oi Sze","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Therese","family":"Baysari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane Ellen","family":"Carland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indy","family":"Sandaradura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Osborne","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,28]]},"reference":[{"key":"2525_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC et al (2009) Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 66:82\u201398. \n                    https:\/\/doi.org\/10.2146\/ajhp080434","journal-title":"Am J Health Syst Pharm"},{"key":"2525_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.1365-2125.1998.00770","volume":"46","author":"AS Gross","year":"1998","unstructured":"Gross AS (1998) Best practice in therapeutic drug monitoring. Br J Clin Pharmacol 46:95\u201399. \n                    https:\/\/doi.org\/10.1046\/j.1365-2125.1998.00770","journal-title":"Br J Clin Pharmacol"},{"key":"2525_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jsps.2014.11.005","volume":"23","author":"M Za\u2019abi Al","year":"2015","unstructured":"Al Za\u2019abi M, Al Muqbali J, Al-Waili K (2015) Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman. Saudi Pharm J 23:458\u2013462. \n                    https:\/\/doi.org\/10.1016\/j.jsps.2014.11.005","journal-title":"Saudi Pharm J"},{"key":"2525_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/MAJ.0000000000000368","volume":"349","author":"S Koppula","year":"2015","unstructured":"Koppula S, Ruben S, Bangash F et al (2015) Pitfalls in dosing vancomycin. Am J Med Sci 349:137\u2013139. \n                    https:\/\/doi.org\/10.1097\/MAJ.0000000000000368","journal-title":"Am J Med Sci"},{"key":"2525_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/00365540903413614","volume":"42","author":"M Roustit","year":"2010","unstructured":"Roustit M, Fran\u00e7ois P, Sellier E et al (2010) Evaluation of glycopeptide prescription and therapeutic drug monitoring at a university hospital. Scand J Infect Dis 42:177\u2013184. \n                    https:\/\/doi.org\/10.3109\/00365540903413614","journal-title":"Scand J Infect Dis"},{"key":"2525_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1309\/AJCPDSYS0DVLKFOH","volume":"137","author":"AP Morrison","year":"2012","unstructured":"Morrison AP, Melanson SE, Carty MG et al (2012) What proportion of vancomycin trough levels are drawn too early?: frequency and impact on clinical actions. Am J Clin Pathol 137:472\u2013478. \n                    https:\/\/doi.org\/10.1309\/AJCPDSYS0DVLKFOH","journal-title":"Am J Clin Pathol"},{"key":"2525_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2146\/ajhp090661","volume":"68","author":"KA Traugott","year":"2011","unstructured":"Traugott KA, Maxwell PR, Green K et al (2011) Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders. Am J Health Syst Pharm 68:347\u2013352. \n                    https:\/\/doi.org\/10.2146\/ajhp090661","journal-title":"Am J Health Syst Pharm"},{"key":"2525_CR8","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","volume":"166","author":"LK Hidayat","year":"2006","unstructured":"Hidayat LK, Hsu DI, Quist R et al (2006) High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 166:2138\u20132144. \n                    https:\/\/doi.org\/10.1001\/archinte.166.19.2138","journal-title":"Arch Intern Med"},{"key":"2525_CR9","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","volume":"29","author":"MN Jeffres","year":"2007","unstructured":"Jeffres MN, Isakow W, Doherty JA et al (2007) A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther 29:1107\u20131115. \n                    https:\/\/doi.org\/10.1016\/j.clinthera.2007.06.014","journal-title":"Clin Ther"},{"key":"2525_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1586\/14787210.2015.1041924","volume":"13","author":"JY Lee","year":"2015","unstructured":"Lee JY, Howden BP (2015) Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician\u2019s guide to the science informing current practice. Expert Rev Anti-Infect Ther 13:855\u2013869. \n                    https:\/\/doi.org\/10.1586\/14787210.2015.1041924","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"2525_CR11","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1086\/420937","volume":"38","author":"B Spellberg","year":"2004","unstructured":"Spellberg B, Powers JH, Brass EP et al (2004) Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 38:1279\u20131286. \n                    https:\/\/doi.org\/10.1086\/420937","journal-title":"Clin Infect Dis"},{"key":"2525_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher HW, Talbot GH, Bradley JS et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1\u201312. \n                    https:\/\/doi.org\/10.1086\/595011","journal-title":"Clin Infect Dis"},{"key":"2525_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE et al (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159\u2013177. \n                    https:\/\/doi.org\/10.1086\/510393","journal-title":"Clin Infect Dis"},{"key":"2525_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/cid\/cit212","volume":"57","author":"E Charani","year":"2013","unstructured":"Charani E, Castro-Sanchez E, Sevdalis N et al (2013) Understanding the determinants of antimicrobial prescribing within hospitals: the role of \u201cprescribing etiquette\u201d. Clin Infect Dis 57:188\u2013196. \n                    https:\/\/doi.org\/10.1093\/cid\/cit212","journal-title":"Clin Infect Dis"},{"key":"2525_CR15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/imj.12373","volume":"44","author":"N Chaves","year":"2014","unstructured":"Chaves N, Cheng A, Runnegar N et al (2014) Analysis of knowledge and attitude surveys to identify barriers and enablers of appropriate antimicrobial prescribing in three Australian tertiary hospitals. Intern Med J 44:568\u2013574. \n                    https:\/\/doi.org\/10.1111\/imj.12373","journal-title":"Intern Med J"},{"key":"2525_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jac\/dkn143","volume":"62","author":"PJ Cortoos","year":"2008","unstructured":"Cortoos PJ, De Witte K, Peetermans WE et al (2008) Opposing expectations and suboptimal use of a local antibiotic hospital guideline: a qualitative study. J Antimicrob Chemother 62:189\u2013195. \n                    https:\/\/doi.org\/10.1093\/jac\/dkn143","journal-title":"J Antimicrob Chemother"},{"key":"2525_CR17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/jac\/dkl323","volume":"58","author":"V Souza De","year":"2006","unstructured":"De Souza V, MacFarlane A, Murphy AW et al (2006) A qualitative study of factors influencing antimicrobial prescribing by non-consultant hospital doctors. J Antimicrob Chemother 58:840\u2013843. \n                    https:\/\/doi.org\/10.1093\/jac\/dkl323","journal-title":"J Antimicrob Chemother"},{"key":"2525_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/imj.12627","volume":"45","author":"N Diasinos","year":"2015","unstructured":"Diasinos N, Baysari M, Kumar S et al (2015) Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines? Intern Med J 45:55\u201362. \n                    https:\/\/doi.org\/10.1111\/imj.12627","journal-title":"Intern Med J"},{"key":"2525_CR19","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1001\/archinte.164.15.1662","volume":"164","author":"TB Giblin","year":"2004","unstructured":"Giblin TB, Sinkowitz-Cochran RL, Harris PL et al (2004) Clinicians\u2019 perceptions of the problem of antimicrobial resistance in health care facilities. Arch Intern Med 164:1662\u20131668. \n                    https:\/\/doi.org\/10.1001\/archinte.164.15.1662","journal-title":"Arch Intern Med"},{"key":"2525_CR20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1017\/ice.2015.136","volume":"36","author":"D Livorsi","year":"2015","unstructured":"Livorsi D, Comer A, Matthias MS et al (2015) Factors influencing antibiotic-prescribing decisions among inpatient physicians: a qualitative investigation. Infect Control Hosp Epidemiol 36:1065\u20131072. \n                    https:\/\/doi.org\/10.1017\/ice.2015.136","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2525_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/jhm.2495","volume":"11","author":"D Livorsi","year":"2015","unstructured":"Livorsi D, Comer AR, Matthias MS et al (2015) Barriers to guideline-concordant antibiotic use among inpatient physicians: a case vignette qualitative study. J Hosp Med 11:174\u2013180. \n                    https:\/\/doi.org\/10.1002\/jhm.2495","journal-title":"J Hosp Med"},{"key":"2525_CR22","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1093\/jac\/dku093","volume":"69","author":"K Mattick","year":"2014","unstructured":"Mattick K, Kelly N, Rees C (2014) A window into the lives of junior doctors: narrative interviews exploring antimicrobial prescribing experiences. J Antimicrob Chemother 69:2274\u20132283. \n                    https:\/\/doi.org\/10.1093\/jac\/dku093","journal-title":"J Antimicrob Chemother"},{"key":"2525_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1309\/AJCPKQ6EAH7OYQLB","volume":"140","author":"SE Melanson","year":"2013","unstructured":"Melanson SE, Mijailovic AS, Wright AP et al (2013) An intervention to improve the timing of vancomycin levels. Am J Clin Pathol 140:801\u2013806. \n                    https:\/\/doi.org\/10.1309\/AJCPKQ6EAH7OYQLB","journal-title":"Am J Clin Pathol"},{"key":"2525_CR24","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3201\/eid1003.030292","volume":"10","author":"P Mol","year":"2004","unstructured":"Mol P, Rutten W, Gans R et al (2004) Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands. Emerg Infect Dis 10:522\u2013525. \n                    https:\/\/doi.org\/10.3201\/eid1003.030292","journal-title":"Emerg Infect Dis"},{"key":"2525_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/ejhpharm-2014-000483","volume":"22","author":"R Newham","year":"2015","unstructured":"Newham R, Thomson A, Semple Y et al (2015) Barriers to the safe and effective use of intravenous gentamicin and vancomycin in Scottish hospitals, and strategies for quality improvement. Eur J Hosp Pharm 22:32\u201337. \n                    https:\/\/doi.org\/10.1136\/ejhpharm-2014-000483","journal-title":"Eur J Hosp Pharm"},{"key":"2525_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/qshc.2005.017327","volume":"16","author":"JA Schouten","year":"2007","unstructured":"Schouten JA, Hulscher ME, Natsch S et al (2007) Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study. BMJ Qual Saf 16:143\u2013149. \n                    https:\/\/doi.org\/10.1136\/qshc.2005.017327","journal-title":"BMJ Qual Saf"},{"key":"2525_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/qshc.2004.012534","volume":"15","author":"J Tan","year":"2006","unstructured":"Tan J, Naik V, Lingard L (2006) Exploring obstacles to proper timing of prophylactic antibiotics for surgical site infections. BMJ Qual Saf 15:32\u201338. \n                    https:\/\/doi.org\/10.1136\/qshc.2004.012534","journal-title":"BMJ Qual Saf"},{"key":"2525_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/j.2055-2335.2013.tb00212","volume":"43","author":"CK Teo","year":"2013","unstructured":"Teo CK, Baysari MT, Day RO (2013) Understanding compliance to an antibiotic prescribing policy: perspectives of policymakers and prescribers. J Pharm Pract Res 43:32\u201336. \n                    https:\/\/doi.org\/10.1002\/j.2055-2335.2013.tb00212","journal-title":"J Pharm Pract Res"},{"key":"2525_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/ijpp.12086","volume":"22","author":"J Warburton","year":"2014","unstructured":"Warburton J, Hodson K, James D (2014) Antibiotic intravenous-to-oral switch guidelines: barriers to adherence and possible solutions. Int J Pharm Prac 22:345\u2013353. \n                    https:\/\/doi.org\/10.1111\/ijpp.12086","journal-title":"Int J Pharm Prac"},{"key":"2525_CR30","unstructured":"Antibiotic Expert Group (2016). Therapeutic Guidelines: Antibiotic (Version 15). \n                    https:\/\/tgldcdp.tg.org.au\/guideLine?guidelinePage=Antibiotic&frompage=etgcomplete\n                    \n                  . Accessed 26 January 2018"},{"key":"2525_CR31","first-page":"925","volume-title":"Encyclopedia of case study research","author":"JC Lapadat","year":"2010","unstructured":"Lapadat JC (2010) Thematic analysis. In: Mills AJ, Durepos G, Wiebe E (eds) Encyclopedia of case study research. SAGE Publications, Inc., California, pp 925\u2013927"},{"key":"2525_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1098214005283748","volume":"27","author":"DR Thomas","year":"2006","unstructured":"Thomas DR (2006) A general inductive approach for analyzing qualitative evaluation data. Am J Eval 27:237\u2013246. \n                    https:\/\/doi.org\/10.1177\/1098214005283748","journal-title":"Am J Eval"},{"key":"2525_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1258\/jrsm.2009.090150","volume":"102","author":"PJ Lewis","year":"2009","unstructured":"Lewis PJ, Tully MP (2009) Uncomfortable prescribing decisions in hospitals: the impact of teamwork. J R Soc Med 102:481\u2013488. \n                    https:\/\/doi.org\/10.1258\/jrsm.2009.090150","journal-title":"J R Soc Med"},{"key":"2525_CR34","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1136\/bmjqs-2012-001175","volume":"22","author":"S Ross","year":"2013","unstructured":"Ross S, Ryan C, Duncan EM et al (2013) Perceived causes of prescribing errors by junior doctors in hospital inpatients: a study from the PROTECT programme. BMJ Qual Saf 22:2297\u20132102. \n                    https:\/\/doi.org\/10.1136\/bmjqs-2012-001175","journal-title":"BMJ Qual Saf"},{"key":"2525_CR35","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/bmjqs-2011-000308","volume":"21","author":"CE Payne","year":"2012","unstructured":"Payne CE, Stein JM, Leong T et al (2012) Avoiding handover fumbles: a controlled trial of a structured handover tool versus traditional handover methods. BMJ Qual Saf 21:925\u2013932. \n                    https:\/\/doi.org\/10.1136\/bmjqs-2011-000308","journal-title":"BMJ Qual Saf"},{"key":"2525_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/bmjqs-2014-003903","volume":"25","author":"TL Zakrison","year":"2016","unstructured":"Zakrison TL, Rosenbloom B, McFarlan A et al (2016) Lost information during the handover of critically injured trauma patients: a mixed-methods study. BMJ Qual Saf 25:929\u2013936. \n                    https:\/\/doi.org\/10.1136\/bmjqs-2014-003903","journal-title":"BMJ Qual Saf"},{"key":"2525_CR37","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/bmjqs-2012-000824","volume":"21","author":"S Egan","year":"2012","unstructured":"Egan S, Murphy PG, Fennell JP et al (2012) Using six sigma to improve once daily gentamicin dosing and therapeutic drug monitoring performance. BMJ Qual Saf 21:1042\u20131051. \n                    https:\/\/doi.org\/10.1136\/bmjqs-2012-000824","journal-title":"BMJ Qual Saf"},{"key":"2525_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s11096-012-9614-6","volume":"34","author":"M Swartling","year":"2012","unstructured":"Swartling M, Gupta R, Dudas V et al (2012) Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. Int J Clin Pharm 34:282\u2013285. \n                    https:\/\/doi.org\/10.1007\/s11096-012-9614-6","journal-title":"Int J Clin Pharm"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2525-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2525-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2525-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T03:39:19Z","timestamp":1569123559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2525-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,28]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2525"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2525-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,28]]},"assertion":[{"value":"26 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}